Developing Clinical Practice Guidelines

Types of Evidence and Outcomes ; Values and Economics, Synthesis, Grading, and Presentation and Deriving Recommendations

Published in: Implementation Science, v. 7, no. 61, July 2012

Posted on RAND.org on July 01, 2012

by Steven H. Woolf, Holger J. Schünemann, Martin P. Eccles, Jeremy M. Grimshaw, Paul G. Shekelle

Read More

Access further information on this document at Implementation Science

This article was published outside of RAND. The full text of the article can be found at the link above.

Clinical practice guidelines are one of the foundations of efforts to improve healthcare. In 1999, we authored a paper about methods to develop guidelines. Since it was published, the methods of guideline development have progressed both in terms of methods and necessary procedures and the context for guideline development has changed with the emergence of guideline clearinghouses and large scale guideline production organisations (such as the UK National Institute for Health and Clinical Excellence). It therefore seems timely to, in a series of three articles, update and extend our earlier paper. In this second paper, we discuss issues of identifying and synthesizing evidence: deciding what type of evidence and outcomes to include in guidelines; integrating values into a guideline; incorporating economic considerations; synthesis, grading, and presentation of evidence; and moving from evidence to recommendations.

Research conducted by

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.